U
Takeda Pharmaceutical Company Limited TAKWI
NYSE
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
$45.65B
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
$0.8548
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$30.24B
EBITDA (TTM)
$7.69B
EBIT (TTM)
$3.24B
Net Income (TTM)
$1.37B
Balance Sheet
Total Assets (Q)
$96.09B
Total Debt (Q)
$34.55B
Total Liabilities (Q)
$48.90B
Book Value Per Share (Q)
$29.77
Cash Flow
Cash from Operations (TTM)
$7.38B
Cash from Investing (TTM)
-$2.68B
Cash from Financing (TTM)
-$3.40B
Net Change in Cash (TTM)
$1.34B
Filings
Filing Date
Thursday, January 30, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jun 23 and 27 (est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
-- - --
52-week High
-- - --
Valuation
Market Cap
$45.65B - Large Cap
Enterprise Value
$80.26B
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
1.59B
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.takeda.com
Phone Number
81 3 3278-2111
Address
1-1, Nihonbashi-Honcho 2-chome
Tokyo, 103-8668
Country
Japan
Year Founded
1781
Business Description
Sector
--
Industry
--
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers... more